Skip to main content
Top
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)

Authors: Ilaria Izzo, Maria A Forleo, Salvatore Casari, Eugenia Quiros-Roldan, Michele Magoni, Giampiero Carosi, Carlo Torti

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Detectable HIV RNA in mothers at delivery is an important risk factor for HIV transmission to newborns. Our hypothesis was that, in migrant women, the risk of detectable HIV RNA at delivery is greater owing to late HIV diagnosis. Therefore, we examined pregnant women by regional provenance and measured variables that could be associated with detectable HIV RNA at delivery.

Methods

A observational retrospective study was conducted from January 1999 to May 2008. Univariate and multivariable regression analyses (generalized linear models) were used, with detectable HIV RNA at delivery as dependent variable.

Results

The overall population comprised 154 women (46.8% migrants). Presentation was later in migrant women than Italians, as assessed by CD4-T-cell count at first contact (mean 417/mm3 versus 545/mm3, respectively; p = 0.003). Likewise, HIV diagnosis was made before pregnancy and HAART was already prescribed at the time of pregnancy in more Italians (91% and 75%, respectively) than migrants (61% and 42.8%, respectively). A subgroup of women with available HIV RNA close to term (i.e., ≤30 days before labour) was studied for risk factors of detectable HIV RNA (≥50 copies/ml) at delivery. Among 93 women, 25 (26.9%) had detectable HIV RNA. A trend toward an association between non-Italian nationality and detectable HIV RNA at delivery was demonstrated by univariate analysis (relative risk, RR = 1.86; p = 0.099). However, by multivariable regression analysis, the following factors appeared to be more important: lack of stable (i.e., ≥14 days) antiretroviral therapy at the time of HIV RNA testing (RR = 4.3; p < 0.0001), and higher CD4+ T-cell count at pregnancy (per 50/mm3, RR = 0.94; p = 0.038).

Conclusions

These results reinforce the importance of extensive screening for HIV infection, earlier initiation of antiretroviral therapy and stricter monitoring of pregnant women to reduce the risk of detectable HIV RNA at delivery. Public health interventions should be particularly targeted to migrant women who are frequently unaware of their HIV status at the time of pregnancy.
Appendix
Available only for authorised users
Literature
2.
go back to reference CDC: Progress toward elimination of perinatal HIV infection-Michigan 1993-2000. MMWR Morb Mortal Wkly Rep. 2002, 51: 93-97. CDC: Progress toward elimination of perinatal HIV infection-Michigan 1993-2000. MMWR Morb Mortal Wkly Rep. 2002, 51: 93-97.
3.
go back to reference Moferson L, Lambert JS, Stiehm R, et al: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med. 1999, 341 (6): 385-93. 10.1056/NEJM199908053410601.CrossRef Moferson L, Lambert JS, Stiehm R, et al: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med. 1999, 341 (6): 385-93. 10.1056/NEJM199908053410601.CrossRef
4.
go back to reference Katz IT, Shapiro R, Li D, et al: Risk factors for detectable HIV RNA at delivery among women receiving highly active antiretroviral therapy in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr. 2010, 54 (1): 27-34.PubMedPubMedCentral Katz IT, Shapiro R, Li D, et al: Risk factors for detectable HIV RNA at delivery among women receiving highly active antiretroviral therapy in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr. 2010, 54 (1): 27-34.PubMedPubMedCentral
5.
go back to reference European Collaborative Study: Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antivir Ther. 2010, 15 (1): 41-9. 10.3851/IMP1489.CrossRefPubMedCentral European Collaborative Study: Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. Antivir Ther. 2010, 15 (1): 41-9. 10.3851/IMP1489.CrossRefPubMedCentral
6.
go back to reference Baroncelli S, Tamburrini E, Ravizza M, for the Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy, et al: Antiretroviral Treatment in pregnancy: a six-year perspective on recent trends in prescriptions patterns, viral load suppression, and pregnancy outcomes. AIDS Patients Care and STDs. 2009, 23 (7): 513-20. 10.1089/apc.2008.0263.CrossRef Baroncelli S, Tamburrini E, Ravizza M, for the Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy, et al: Antiretroviral Treatment in pregnancy: a six-year perspective on recent trends in prescriptions patterns, viral load suppression, and pregnancy outcomes. AIDS Patients Care and STDs. 2009, 23 (7): 513-20. 10.1089/apc.2008.0263.CrossRef
8.
go back to reference Heard I, Sitta R, Lert F: Reproductive choice in men and women living with HIV: evidence from a large representative sample of outpatients attending French hospitals (ARS-EN12-VESPA Study). AIDS. 2007, 21 (S1): S77-82. 10.1097/01.aids.0000255089.44297.6f.CrossRefPubMed Heard I, Sitta R, Lert F: Reproductive choice in men and women living with HIV: evidence from a large representative sample of outpatients attending French hospitals (ARS-EN12-VESPA Study). AIDS. 2007, 21 (S1): S77-82. 10.1097/01.aids.0000255089.44297.6f.CrossRefPubMed
9.
go back to reference Towsend CL, Cortina-Borja M, Pecham CS, Tookey PA: Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG. 2008, 115: 1078-1986. 10.1111/j.1471-0528.2008.01706.x.CrossRef Towsend CL, Cortina-Borja M, Pecham CS, Tookey PA: Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG. 2008, 115: 1078-1986. 10.1111/j.1471-0528.2008.01706.x.CrossRef
10.
go back to reference Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J: Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. Acta Obstet Gynecol Scand. 2009, 88 (8): 882-7. 10.1080/00016340903062836.CrossRefPubMed Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J: Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. Acta Obstet Gynecol Scand. 2009, 88 (8): 882-7. 10.1080/00016340903062836.CrossRefPubMed
12.
go back to reference Krivine A, Launay O, Firtion G, et al: Does HIV-1 subtype D have higher risk of vertical transmission then other HIV subtypes?. JID. 2009, 199: 1533-10.1086/598481.CrossRef Krivine A, Launay O, Firtion G, et al: Does HIV-1 subtype D have higher risk of vertical transmission then other HIV subtypes?. JID. 2009, 199: 1533-10.1086/598481.CrossRef
Metadata
Title
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)
Authors
Ilaria Izzo
Maria A Forleo
Salvatore Casari
Eugenia Quiros-Roldan
Michele Magoni
Giampiero Carosi
Carlo Torti
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-124

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue